PositoAI/ US/ Medpace Holdings, Inc.

Medpace Holdings, Inc.

NasdaqGS: MEDP · Healthcare

Positivity Index

#6,266 / 6,774

Global

#3,572 / 4,000

United States

Positivity Score

570

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

Medpace Holdings, Inc. — Overview & Financial Snapshot

Medpace Holdings, Inc. (NasdaqGS: MEDP) is a Healthcare company, ranked #6,266 of 6,774 companies globally and #3,572 of 4,000 in United States on PositoAI, with a Positivity Score of 570. Its market capitalisation is ₹1.72 lakh Cr ($18.25B), P/E ratio is 36.3 and P/B ratio is 42.07. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

P/B Ratio 42.07

P/E Ratio 36.3

D/E Ratio 0.33

ROE 162.15%

Owes vs Owns ? 0.79× Moderate $0.79 owed for every $1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹1,699.98$18.01

Forward EPS ₹1,828.35$19.37

Beta 1.18

Market Cap ₹1.72 lakh Cr$18.25B

What these numbers mean →

What does Medpace Holdings, Inc. do?

What is Medpace Holdings, Inc.'s P/E and P/B ratio?

Medpace Holdings, Inc. has a P/E ratio of 36.3 and a P/B ratio of 42.07.

What is Medpace Holdings, Inc.'s debt-to-equity ratio?

Medpace Holdings, Inc. has a debt-to-equity ratio of 0.33.

How much does Medpace Holdings, Inc. owe compared with what it owns?

Medpace Holdings, Inc. owes $0.79 for every $1 it owns (balance sheet Jun 2026), which is moderate.

What is Medpace Holdings, Inc.'s Positivity rank?

Medpace Holdings, Inc. is ranked #6,266 of 6,774 companies globally and #3,572 of 4,000 in United States on PositoAI, with a Positivity Score of 570.

Does Medpace Holdings, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Medpace Holdings, Inc..

Where can I read the latest news about Medpace Holdings, Inc.?

Recent headlines about Medpace Holdings, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Medpace Holdings, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Medpace Holdings, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.